What if one of the most attractive sources of uncorrelated returns is not new at all - but simply being applied where no one has looked yet?

For decades, royalty investing has quietly generated billions in value across pharmaceuticals, mining, and music. Investors in these sectors have benefited from long-duration, predictable cash flows linked